NCT01723748View on ClinicalTrials.gov

Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
AcromegalyMetabolic Diseases
Interventions
DRUG

genotropin

iii) intravenous exogenous bolus of GH (0.5 mg) followed by muscle and fat biopsies.

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT01723748 - Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects | Biotech Hunter | Biotech Hunter